Synopsis
Synopsis
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 981-34-0
2. 16-beta Methyl Epoxide
3. (4as,4bs,5as,6as,7r,8s,9as,9bs)-7-hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4ah)-one
4. M9ay9bsi41
5. 9beta,11beta-epoxy-17alpha,21-dihydroxy-16beta-methylene-pregna-1,4-diene-3,20-dione
6. 9beta,11beta-epoxy-17,21-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
7. (9beta,11beta,16beta)-9,11-epoxy-17,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
8. (1s,2s,10s,11s,13s,14r,15s,17s)-14-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one
9. Einecs 213-563-4
10. Unii-m9ay9bsi41
11. 9,11?-epoxy-17,21-dihydroxy-16?-methyl-9?-pregna-1,4-diene-3,20-dione
12. 16-beta-methyl Epoxide
13. Schembl5262836
14. 9
15. A,11
16. A-epoxy-17,21-dihydroxy-16
17. A-methylpregna-1,4-diene-3,20-dione
18. (11alpha,16alpha)-9,11-epoxy-17,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
19. Dtxsid601020538
20. 14622-47-0
21. Amy27801
22. Zinc6066702
23. Mfcd09038712
24. Akos017343721
25. Cs-w006439
26. As-17685
27. Pregna-1,4-diene-3,20-dione, 9,11-epoxy-17,21-dihydroxy-16-methyl-, (9.beta.,11.beta.,16.beta.)-
28. Betamethasone Impurity E [ep Impurity]
29. C77355
30. 981m340
31. A855442
32. W-100093
33. Q27283711
34. Beclomethasone Dipropionate Impurity R [ep Impurity]
35. 9 Beta ,11 Beta -epoxy-17,21-dihydroxy-16 Beta -methylpregna-1,4-diene-3,20-dione
36. 16alpha-methyl Epoxide(db-11); 17alpha,21-dihydroxy-9alpha,11alpha,epoxy-16alpha-methylpregn-1,4-diene-3,20-dione
37. 9,11.beta.-epoxy-17,21-dihydroxy-16.beta.-methyl-9.beta.-pregna-1,4-diene-3,20-dione
38. 9.beta.-pregna-1,4-diene-3,20-dione, 9,11.beta.-epoxy-17,21-dihydroxy-16.beta.-methyl-
Molecular Weight | 372.5 g/mol |
---|---|
Molecular Formula | C22H28O5 |
XLogP3 | 2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 372.19367399 g/mol |
Monoisotopic Mass | 372.19367399 g/mol |
Topological Polar Surface Area | 87.1 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 814 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Betamethyl Epoxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Betamethyl Epoxide, including repackagers and relabelers. The FDA regulates Betamethyl Epoxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Betamethyl Epoxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Betamethyl Epoxide supplier is an individual or a company that provides Betamethyl Epoxide active pharmaceutical ingredient (API) or Betamethyl Epoxide finished formulations upon request. The Betamethyl Epoxide suppliers may include Betamethyl Epoxide API manufacturers, exporters, distributors and traders.
click here to find a list of Betamethyl Epoxide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Betamethyl Epoxide DMF (Drug Master File) is a document detailing the whole manufacturing process of Betamethyl Epoxide active pharmaceutical ingredient (API) in detail. Different forms of Betamethyl Epoxide DMFs exist exist since differing nations have different regulations, such as Betamethyl Epoxide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Betamethyl Epoxide DMF submitted to regulatory agencies in the US is known as a USDMF. Betamethyl Epoxide USDMF includes data on Betamethyl Epoxide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Betamethyl Epoxide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Betamethyl Epoxide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Betamethyl Epoxide Drug Master File in Japan (Betamethyl Epoxide JDMF) empowers Betamethyl Epoxide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Betamethyl Epoxide JDMF during the approval evaluation for pharmaceutical products. At the time of Betamethyl Epoxide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Betamethyl Epoxide suppliers with JDMF on PharmaCompass.
A Betamethyl Epoxide CEP of the European Pharmacopoeia monograph is often referred to as a Betamethyl Epoxide Certificate of Suitability (COS). The purpose of a Betamethyl Epoxide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Betamethyl Epoxide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Betamethyl Epoxide to their clients by showing that a Betamethyl Epoxide CEP has been issued for it. The manufacturer submits a Betamethyl Epoxide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Betamethyl Epoxide CEP holder for the record. Additionally, the data presented in the Betamethyl Epoxide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Betamethyl Epoxide DMF.
A Betamethyl Epoxide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Betamethyl Epoxide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Betamethyl Epoxide suppliers with CEP (COS) on PharmaCompass.
Betamethyl Epoxide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Betamethyl Epoxide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Betamethyl Epoxide GMP manufacturer or Betamethyl Epoxide GMP API supplier for your needs.
A Betamethyl Epoxide CoA (Certificate of Analysis) is a formal document that attests to Betamethyl Epoxide's compliance with Betamethyl Epoxide specifications and serves as a tool for batch-level quality control.
Betamethyl Epoxide CoA mostly includes findings from lab analyses of a specific batch. For each Betamethyl Epoxide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Betamethyl Epoxide may be tested according to a variety of international standards, such as European Pharmacopoeia (Betamethyl Epoxide EP), Betamethyl Epoxide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Betamethyl Epoxide USP).
LOOKING FOR A SUPPLIER?